Fundraising FoxFlying L Partners — Full Portfolio
11 tracked investments · listed companies and verified rows first
RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(President, Chief Executive Officer & Director)Mark Wilterding(Chief Financial Officer)in
Co-investorsForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA CapitalVisionary Ventures+2 more
Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.
BiotechHealthtechMedical Devices
Bobak Azamian(Founder)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)Aziz Mottiwala(Chief Commercial Officer)inDianne Whitfield(Chief Human Resources Officer)inElizabeth Yeu-Lin(Chief Medical Officer)
Co-investorsAPERTURE Venture PartnersFrazier Life SciencesVisionary VenturesVivo CapitalBain Capital Life SciencesRTW Investments L.P.
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)William J. Link(Director)
Co-investorsEvidity Health CapitalRevelation PartnersHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Venture AIV HoldingsVersant Ventures
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsVisionary VenturesDeerfield Management Company
HealthtechSioux Falls, US
TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)
BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)
Co-investorsVersant Venture AIV Holdings
Falcon Vision is a Hungarian company active in industrial digitalization and lean management, associated with the Magyar DigiLean Egyesület (Hungarian DigiLean Association) and its industrial exhibition activities.
Advanced ManufacturingEnterprise Software
Co-investorsV4C Advisers Sp. Z.o.o.
Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain.
HealthtechMedical Devices
Co-investorsTrinity Capital
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardWilliam J Link(Director)Ali Behbahani(Director)in
Co-investorsNew Enterprise Associates (NEA)Versant Venture AIV HoldingsVersant VenturesVida Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)in
BoardWilliam Link(Director)Jeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Co-investorsVisionary VenturesVersant Venture AIV Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CorneagenSurface Pharmaceuticals, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.